CS208475B2 - Method of making the hydrogencitrate of the alcalic met - Google Patents

Method of making the hydrogencitrate of the alcalic met Download PDF

Info

Publication number
CS208475B2
CS208475B2 CS783982A CS398278A CS208475B2 CS 208475 B2 CS208475 B2 CS 208475B2 CS 783982 A CS783982 A CS 783982A CS 398278 A CS398278 A CS 398278A CS 208475 B2 CS208475 B2 CS 208475B2
Authority
CS
Czechoslovakia
Prior art keywords
citric acid
weight
citrate
urine
ions
Prior art date
Application number
CS783982A
Other languages
Czech (cs)
English (en)
Inventor
Rolf Madaus
Werner Stumpf
Klaus Goerler
Alfonso C Beltran
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of CS208475B2 publication Critical patent/CS208475B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265Citric acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS783982A 1977-06-16 1978-06-16 Method of making the hydrogencitrate of the alcalic met CS208475B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2727304A DE2727304C2 (de) 1977-06-16 1977-06-16 Saures Alkalicitrat, dessen Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
CS208475B2 true CS208475B2 (en) 1981-09-15

Family

ID=6011690

Family Applications (1)

Application Number Title Priority Date Filing Date
CS783982A CS208475B2 (en) 1977-06-16 1978-06-16 Method of making the hydrogencitrate of the alcalic met

Country Status (26)

Country Link
US (1) US4820870A (sv)
JP (1) JPS545912A (sv)
AR (1) AR219109A1 (sv)
AU (1) AU519032B2 (sv)
BE (1) BE868089A (sv)
BG (1) BG41657A3 (sv)
CA (1) CA1133506A (sv)
CH (1) CH634813A5 (sv)
CS (1) CS208475B2 (sv)
DE (1) DE2727304C2 (sv)
DK (1) DK270578A (sv)
FR (1) FR2394513A1 (sv)
GB (1) GB1583840A (sv)
GR (1) GR64516B (sv)
HK (1) HK46481A (sv)
IL (1) IL54734A (sv)
IT (1) IT1214864B (sv)
MX (1) MX4999E (sv)
NL (1) NL174345C (sv)
PL (1) PL118528B1 (sv)
PT (1) PT68096A (sv)
RO (1) RO76941A (sv)
SE (1) SE438851B (sv)
SU (1) SU812167A3 (sv)
YU (1) YU41105B (sv)
ZA (1) ZA783409B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6393968A (ja) * 1986-10-06 1988-04-25 株式会社フジタ 地下立体駐車場
JPH02104870A (ja) * 1988-10-11 1990-04-17 Iwataro Moriyama 駐車装置
DE4328577C2 (de) * 1993-08-25 1997-09-11 Madaus Ag Alkalicitrate und deren Verwendung als Arzneimittel
DE4409949C2 (de) * 1994-03-23 1996-11-21 Madaus Ag Verwendung von Calcium-Alkalicitraten zur Prophylaxe und Behandlung degenerativer Erkrankungen des Knochengerüstes
ATE176662T1 (de) * 1994-03-23 1999-02-15 Madaus Ag Calcium-alkalicitratverbindungen und deren verwendung als arzneimittel
DE4409948A1 (de) * 1994-03-23 1995-09-28 Madaus Ag Calcium-Alkalicitratverbindungen und deren Verwendung als Arzneimittel
US11273140B2 (en) 2013-06-06 2022-03-15 Stefanie A. Seixas-Mikelus Juice beverage for prevention and treatment of renal stones
EP3532083A4 (en) * 2016-10-27 2020-07-22 Seixas-Mikelus, Stefanie, A. JUICE-BASED DRINK TO PREVENT AND TREAT RENAL CALCULATIONS
PL238507B1 (pl) 2018-11-27 2021-08-30 Kozak Dariusz P H M Polcomm Wiertło z podwójnymi nacinakami
CN111116350A (zh) * 2019-12-28 2020-05-08 湖南九典制药股份有限公司 一种枸橼酸氢钾钠的制备方法
CN114404142B (zh) * 2022-02-23 2024-03-29 天津富勤科技股份有限公司 一种产生中性或弱酸性蒸汽的自发热眼罩

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE968843C (de) * 1953-11-29 1958-04-03 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von pharmakologisch wirksamen Magnesiumsalzen der Citronensaeure
DE1016251B (de) * 1955-01-22 1957-09-26 Adolf Christian Josef Opferman Verfahren zur Herstellung von zur Behandlung der Lungentuberkulose dienendem Monomagnesiumdicalciumcitrat
US3658969A (en) * 1969-11-14 1972-04-25 Codex Sa Pharmaceutical compositions useful in citric acid therapy

Also Published As

Publication number Publication date
GB1583840A (en) 1981-02-04
YU142778A (en) 1982-10-31
JPS545912A (en) 1979-01-17
AU3716278A (en) 1979-12-20
PL207657A1 (pl) 1979-06-04
GR64516B (en) 1980-04-09
BE868089A (fr) 1978-12-14
AR219109A1 (es) 1980-07-31
SU812167A3 (ru) 1981-03-07
IT1214864B (it) 1990-01-18
DE2727304A1 (de) 1979-01-04
FR2394513B1 (sv) 1982-11-19
DK270578A (da) 1978-12-17
CH634813A5 (de) 1983-02-28
PT68096A (de) 1978-06-01
HK46481A (en) 1981-09-25
CA1133506A (en) 1982-10-12
NL174345C (nl) 1984-06-01
AU519032B2 (en) 1981-11-05
MX4999E (es) 1983-02-02
SE438851B (sv) 1985-05-13
FR2394513A1 (fr) 1979-01-12
IL54734A0 (en) 1978-07-31
US4820870A (en) 1989-04-11
YU41105B (en) 1986-12-31
SE7806684L (sv) 1978-12-17
BG41657A3 (en) 1987-07-15
PL118528B1 (en) 1981-10-31
NL7805747A (nl) 1978-12-19
IL54734A (en) 1982-09-30
IT7824553A0 (it) 1978-06-14
DE2727304C2 (de) 1982-12-02
NL174345B (nl) 1984-01-02
ZA783409B (en) 1979-07-25
RO76941A (ro) 1981-06-22

Similar Documents

Publication Publication Date Title
Prescott Pharmacokinetic drug interactions
KR100412219B1 (ko) 분자 요오드의 경구투여용 제약 조성물
US8759398B2 (en) Phosphorus binder composition for treatment of hyperphosphatemia
CS208475B2 (en) Method of making the hydrogencitrate of the alcalic met
JPS6075435A (ja) 経口抗糖尿病剤用の新規ガレヌス製剤
SK12692001A3 (sk) Zmesi valdecoxibu
US5006551A (en) Composition for destroying malignant tumors
US20170312309A1 (en) Intradialytic administration of sodium thiosulfate
JP2021512081A (ja) エソメプラゾール及び炭酸水素ナトリウムを含む安定な薬剤学的組成物
FR2688405A1 (fr) Procede d'une preparation d'une solution medicinale stable pour voie orale a liberation controlee, a base d'un beta-bloquant, et composition pharmaceutique a base d'un beta-bloquant.
IE60713B1 (en) Use of athiazide diuretic for the manufacture of a non-diuretic antihypertensive medicament
CA3009332A1 (en) Pharmaceutical formulations for treating kidney stones and methods for fabricating and using thereof
EP0074426B1 (en) Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions
JP2811331B2 (ja) 骨形成促進剤
Roberge et al. Use of sodium polystyrene sulfonate in a lithium overdose
US4447455A (en) Oral urolithiasis remedy
JP2009526086A (ja) 燐酸過剰血による病気を治療する薬物及びその製造方法
JP6063939B2 (ja) L−ヒスチジンおよびその誘導体の新規用途
US7855191B2 (en) Agent having a destructive effect on malignant tumors and method for the production thereof
WO2022216294A1 (en) Powder for oral suspension containing tadalafil
Taraszka et al. Effect of dissolution rate of sulfamethazine from tablets on absorption and excretion of sulfamethazine
JP2022541948A (ja) エソメプラゾール及び炭酸水素ナトリウムを含む安定した薬学的組成物
KR20130047262A (ko) 제어된 방출성의 아스코르빈산 함유 경구용 정제 조성물 및 그 분석방법
RU2101014C1 (ru) Анальгезирующее, противовоспалительное, жаропонижающее лекарственное средство и способ его получения
Sjoden et al. Calcium absorption and excretion in patients treated with verapamil.